AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
AcelRx Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: August 28, 2023
AcelRx Pharmaceuticals reported fiscal year 2022 executive compensation information on August 28, 2023.
In 2022, three executives at AcelRx Pharmaceuticals received on average a compensation package of $958K, a 37% decrease compared to previous year.
Average pay of disclosed executives at AcelRx Pharmaceuticals
Vincent J. Angotti, Chief Executive Officer, received $1.3M in total, which decreased by 47% compared to 2021. 49% of Angotti's compensation, or $637K, was in salary. Angotti also received $258K in non-equity incentive plan, $234K in option awards, $157K in stock awards, as well as $12K in other compensation.
Pamela P. Palmer, Chief Medical Officer, received a compensation package of $822K, which decreased by 24% compared to previous year. 64% of the compensation package, or $526K, was in salary.
Raffi Asadorian, Chief Financial Officer, earned $755K in 2022, a 26% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on August 28, 2023.